Hoth Therapeutics Inc (NASDAQ:HOTH) does about 1.02M shares in volume on a normal day but saw 2781859 shares change hands in the recent trading day. The company now has a market cap of 17.17M USD. Its current market price is $1.30, marking an increase of 7.44% compared to the previous close of $1.21. The 52 week high reached by this stock is $3.80 whilst the lowest price level in 52 weeks is $0.58.
The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 74.0% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 15, 2019 when The Benchmark Company initiated the stock to “Speculative Buy” and issued a price target of $10.
The current price level is 37.71%, 44.83%, and 34.72% away from its SMA20, SMA50, and SMA200 respectively, with the HOTH price moving below the 50-day SMA on current market day. Hoth Therapeutics Inc (HOTH) stock is up 56.57% over the week and 45.17% over the past month. Its price is 73.77% year-to-date and 13.84% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.27 and -0.97 for whole year.
To reach the target analysts have set, the stock logically needs to grow 74.0 percent from here.
Outstanding shares total 13.17M with insiders holding 0.50% of the shares and institutional holders owning 2.31% of the company’s common stock. The company has a return on investment of -83.39% and return on equity of -99.35%. The beta has a value of 0.52. Price to book ratio is 1.48.
